4//SEC Filing
Certel Kaan 4
Accession 0000950170-24-067418
CIK 0001850838other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:57 PM ET
Size
5.5 KB
Accession
0000950170-24-067418
Insider Transaction Report
Form 4
Certel Kaan
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-05-31+220,000→ 220,000 totalExercise: $1.98Exp: 2034-05-30→ Common Stock (220,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable with respect to 25% of the underlying shares on May 28, 2025 and in twelve (12) equal quarterly installments thereafter such that the option will become fully vested and exercisable on May 28, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
Documents
Issuer
Omega Therapeutics, Inc.
CIK 0001850838
Entity typeother
Related Parties
1- filerCIK 0002024211
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 4:57 PM ET
- Size
- 5.5 KB